🇺🇸 FDA
Patent

US 10532040

Methods of treating cancer with herbacetin

granted A61KA61K31/352A61K31/353

Quick answer

US patent 10532040 (Methods of treating cancer with herbacetin) held by Regents of the University of Minnesota expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/352, A61K31/353